ADBiotech Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Nov '24 Nov 14, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	25,502	29,935	30,712	45,092	37,494
Market Cap Growth	-27.86%	-2.53%	-31.89%	20.26%	-
Enterprise Value	31,738	39,459	35,183	49,488	-
Last Close Price	2790.00	3275.00	3360.00	9100.00	7566.67
PE Ratio	-	-	28.35	-	-
PS Ratio	2.60	2.86	2.89	3.81	3.82
PB Ratio	4.53	2.38	1.90	8.83	4.02
P/TBV Ratio	7.32	2.66	1.90	8.84	4.02
P/FCF Ratio	46.92	398.99	-	-	-
P/OCF Ratio	39.50	95.05	-	-	-
EV/Sales Ratio	3.23	3.77	3.31	4.18	-
EV/FCF Ratio	58.39	525.92	-	-	-
Debt / Equity Ratio	2.44	1.08	0.79	2.58	0.78
Debt / FCF Ratio	19.82	181.40	-	-	-
Asset Turnover	0.36	0.35	0.41	0.59	-
Inventory Turnover	2.46	2.79	2.97	3.52	-
Quick Ratio	0.36	0.98	0.89	0.50	0.90
Current Ratio	0.58	1.19	1.20	0.69	1.32
Return on Equity (ROE)	-114.50%	-37.78%	25.33%	-36.92%	-
Return on Assets (ROA)	-10.33%	-10.09%	-11.98%	-4.88%	-
Return on Capital (ROIC)	-12.68%	-10.82%	-13.19%	-5.58%	-
Earnings Yield	-32.72%	-9.57%	8.78%	-5.91%	-19.59%
FCF Yield	2.13%	0.25%	-30.34%	-12.74%	-16.83%
Buyback Yield / Dilution	9.99%	9.33%	-31.17%	-53.77%	-
Total Shareholder Return	9.99%	9.33%	-31.17%	-53.77%	-

Source: S&P Capital IQ. Standard template. Financial Sources.